Key takeaways for New Mexico
- • No GLP-1 is FDA-approved for pre/post-bariatric use specifically.
- • Pre-op: liver shrinkage and risk optimization; post-op: regain management.
- • Observational data show 8-15% additional weight loss post-op on GLP-1.
- • Centennial Care coverage rules apply for Bariatric Pre- and Post-Op Support patients in New Mexico — see Medicaid section below.
- • 13 GLP-1 telehealth providers available nationwide.
Why GLP-1 medications for Bariatric Pre- and Post-Op Support
No GLP-1 is FDA-approved specifically for bariatric pre/post-op support. Off-label preoperative use can reduce liver volume and improve surgical access; off-label postoperative use addresses the roughly 25-30% of bariatric patients who experience clinically significant weight regain. Evidence grade: C (observational data growing; few RCTs). The ASMBS 2022 statement and emerging 2024-2025 consensus recognize this as an evolving practice. Pancreatitis and gastroparesis risks may merit extra caution in altered post-op anatomy.
New Mexico-specific context
New Mexico has telehealth access concentrated in Albuquerque, Las Cruces, Rio Rancho metros, with additional reach to Santa Fe and Roswell. University of New Mexico Health, Presbyterian Healthcare Services is the largest in-state academic medical center for endocrine + obesity-medicine specialty consults. The state health authority publishes prescribing + coverage updates at www.nmhealth.org.
New Mexicotelehealth & pricing rules
- • New Mexico permits audio-only and asynchronous telehealth visits for GLP-1 care.
- • New Mexico allows new-patient telehealth prescribing without a prior in-person visit.
- • Typical cash GLP-1 price in New Mexico: ~$245/mo (compounded options often lower, brand higher).